Coutelle C, Höhn B, Benesova M, Oneta C M, Quattrochi P, Roth H-J, Schmidt-Gayk H, Schneeweiss A, Bastert G, Seitz H K
Department of Medicine and Laboratory of Alcohol Research, Liver Disease and Nutrition, Salem Medical Centre, Heidelberg, Germany.
Int J Oncol. 2004 Oct;25(4):1127-32.
Chronic alcohol consumption is associated with an increased risk for breast cancer, even if consumed in moderate doses. Since acetaldehyde is a carcinogenic factor associated with chronic alcohol consumption, individuals with the alcohol dehydrogenase 1C1 allele (ADH1C1 allele) seem to be at particular risk, since this allele encodes for a rapidly ethanol metabolizing enzyme leading to increased acetaldehyde levels. Since recent epidemiological studies demonstrated an increased risk for breast cancer for individuals with the ADH1C1 allele, we have investigated here ADH1C genotypes in moderate alcohol consumers. Furthermore, estradiols are also known risk factors for breast cancer and acute alcohol ingestion in high doses results in increased serum estradiol concentrations. Thus, in the present study, we tested the effect of low ethanol doses on estrogen serum concentrations. We analyzed the ADH1C genotype in 117 moderate alcohol consumers with breast cancer and in 111 age-matched women with alcohol associated diseases without cancer (74 cirrhotics, 22 patients with pancreatitis and 15 alcohol dependent patients). In addition, 107 healthy controls were studied. Genotyping of the ADH1C-locus was performed using polymerase chain reaction-based restriction fragment length polymorphism methods on leukocyte DNA. To study the effects of ethanol on estradiol levels, ethanol in a dose of 0.225 g/kg body weight was given orally to 8 premenopausal women at various time points of their menstrual cycle. Thereafter estradiol serum concentrations were measured over time. The allele frequency of the ADH1C1 allele was found to be significantly increased in moderate alcohol consumers with breast cancer as compared to age-matched alcoholic controls without cancer (62% vs. 41.9%, p=0.0035). Women with the ADH1C1,1 genotype were found to be 1.8 times more at risk for breast cancer than those with another genotype (95% CI 1.431-2.330, p<0.001). Oral ethanol increased serum estradiol levels significantly by 27-38%. The data demonstrate that moderate alcohol consumers with the ADH1C1 allele have an increased risk to develop breast cancer and even small amounts of alcohol increase serum estradiol levels significantly in premenopausal women especially in the midphase of the menstrual cycle.
长期饮酒与乳腺癌风险增加有关,即使是适量饮酒。由于乙醛是与长期饮酒相关的致癌因素,携带乙醇脱氢酶1C1等位基因(ADH1C1等位基因)的个体似乎尤其危险,因为该等位基因编码一种能快速代谢乙醇的酶,会导致乙醛水平升高。鉴于最近的流行病学研究表明,携带ADH1C1等位基因的个体患乳腺癌的风险增加,我们在此研究了适量饮酒者的ADH1C基因型。此外,雌二醇也是已知的乳腺癌风险因素,高剂量急性摄入酒精会导致血清雌二醇浓度升高。因此,在本研究中,我们测试了低剂量乙醇对雌激素血清浓度的影响。我们分析了117名患乳腺癌的适量饮酒者以及111名年龄匹配的患有酒精相关疾病但无癌症的女性(74名肝硬化患者、22名胰腺炎患者和15名酒精依赖患者)的ADH1C基因型。此外,还研究了107名健康对照者。使用基于聚合酶链反应的限制性片段长度多态性方法对白细胞DNA进行ADH1C基因座的基因分型。为了研究乙醇对雌二醇水平的影响,在月经周期的不同时间点,给8名绝经前女性口服剂量为0.225 g/kg体重的乙醇。此后,随时间测量血清雌二醇浓度。结果发现,与年龄匹配的无癌症酒精对照者相比,患乳腺癌的适量饮酒者中ADH1C1等位基因的频率显著增加(62%对41.9%,p = 0.0035)。发现携带ADH1C1,1基因型的女性患乳腺癌的风险是携带其他基因型女性的1.8倍(95%置信区间1.431 - 2.330,p < 0.001)。口服乙醇使血清雌二醇水平显著升高27% - 38%。数据表明,携带ADH1C1等位基因的适量饮酒者患乳腺癌的风险增加,即使少量酒精也会使绝经前女性尤其是月经周期中期的女性血清雌二醇水平显著升高。